Down 30% in 3 months, is the Taylor Wimpey share price too cheap for me to ignore?

Taylor Wimpey’s share price has plummeted since September and the stock now yields 8%. Should our writer buy the shares for his portfolio?

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

a couple embrace in front of their new home

Image source: Getty Images

Since 19 September, housebuilder Taylor Wimpey (LSE: TW) has seen its share price fall by over 30%.

Why have the shares slumped? One obvious explanation might be that the FTSE 100 company’s trading has disappointed investors. But this hasn’t happened.

Trading as expected

Taylor Wimpey’s recent 2024 trading update confirmed that profits for last year should be “in line with previous guidance”. And 2025 seems to have got off to a reasonable start too. Taylor Wimpey’s order book stood at £1,995m at the end of December, 12.5% higher than the £1,772m reported at the end of 2023.

The company expects to report an increase in completions this year – although weaker pricing in the South of England does mean that the average house price in the order book is 0.5% lower than last year.

This might be one reason for the recent weakness, but this update was only issued on 16 January 2025. It doesn’t explain last year’s slump.

Market headwinds?

My guess is that investors were hoping the government would include some kind of cash bung to boost housing activity with the autumn Budget. Investors may remember how the Help to Buy scheme turbocharged house prices for several years. As it happens, the only promise we’ve got from the government so far is that it will try to unclog the planning system.

One other potential headwind is that interest rates aren’t falling as fast as expected. This has a direct impact on mortgage rates and affordability. That raises the risk of further pressure on house prices.

Is the 8% dividend yield safe?

I think this is a good example of the old stock market adage “buy the rumour, sell the news”.

Shares in Taylor Wimpey and other housebuilders performed very well ahead of October’s Budget. But when the actual news emerged (there wasn’t any), investors took profits. This sell off has left Taylor Wimpey shares trading slightly below their June 2024 book value of 125p. That’s a traditional sign of value for a housebuilders.

I’m also tempted by the 8% forecast dividend yield. However, I’m a little concerned that the forecast payout of 9.4p isn’t fully covered by expected 2024 earnings of 8.2p.

Taylor Wimpey ended last year with net cash of £565m and could probably afford to maintain the dividend. However, management won’t necessarily want to do this. It may want to preserve cash so that it can expand its build rate if market conditions improve.

What’s more, CEO Jennie Daly already has a get-out-of-jail-free card for a dividend cut. Her previous guidance on dividends implied that the payout could fall to a minimum of 7.1p per share, if needed. That would give the stock a more normal 6.1% yield.

My verdict

Right now, I’m on the fence about Taylor Wimpey. I think there’s a chance the stock’s become attractively valued. But I don’t feel it’s definitely too cheap to ignore. I’m also slightly worried about the safety of the dividend.

For these reasons, I’m going to wait until the company’s results are published in February before revisiting this situation.

Roland Head has no position in any of the shares mentioned. The Motley Fool UK has no position in any of the shares mentioned. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Middle-aged white man pulling an aggrieved face while looking at a screen
Market Movers

Down 7%! Why on earth are Imperial Brands shares plummeting today?

Imperial Brands shares are in freefall after a negative reception to fresh trading news. Is the party finally over for…

Read more »

Rear View Of Woman Holding Man Hand during travel in cappadocia
Investing Articles

With a P/E under 7, this value stock looks far too cheap at 101p

This writer reckons value stock Hostelworld (LSE:HSW) looks dirt-cheap as it gets dividends flowing again and builds a social travel…

Read more »

Thoughtful man using his phone while riding on a train and looking through the window
Investing For Beginners

Down 30% in 6 months, I think there’s a big catch to this insanely cheap stock

Jon Smith talks through why careful research is needed when trying to assess if a cheap stock is worth buying…

Read more »

Investing Articles

£5,000 invested in National Grid shares 5 years ago is now worth…

Andrew Mackie takes a closer look at National Grid shares and why short-term market weakness could be missing a powerful…

Read more »

DIVIDEND YIELD text written on a notebook with chart
Investing Articles

How big does an ISA need to be to aim for a £1,500 monthly second income?

Harvey Jones shows how building a balanced portfolio of FTSE 100 dividend stocks can produce a high-and-rising second income in…

Read more »

Person holding magnifying glass over important document, reading the small print
Investing Articles

£20,000 invested in BP shares 1 year ago is now worth…

BP shares have rocketed in the past 12 months, yet analysts think the real growth story is only just beginning,…

Read more »

A pastel colored growing graph with rising rocket.
Investing Articles

A 6.8% forecast yield! 1 often-overlooked FTSE 100 income stock to buy today?

This income stock offers a high forecast yield and strengthening momentum, yet many investors overlook it — creating a rare…

Read more »

GSK scientist holding lab syringe
Investing Articles

GSK’s share price is under £22, but with a ‘fair value’ much higher, is it time for me to buy more right now? 

GSK’s share price rose over the last year, but a huge gap remains between its price and fair value —…

Read more »